Literature DB >> 26984991

First results of a national initiative to enable quality improvement of cardiovascular care by transparently reporting on patient-relevant outcomes.

Dennis van Veghel1, Marloes Marteijn1, Bas de Mol2.   

Abstract

OBJECTIVES: The aims of this study were to assess patient-relevant outcomes of delivered cardiovascular care by focusing on disease management as determined by a multidisciplinary Heart Team, to establish and share best practices by comparing outcomes and to embed value-based decision-making to improve quality and efficiency in Dutch heart centres.
METHODS: In 2014, 12 Dutch heart centres pooled patient-relevant outcome data, which resulted in transparent publication of the outcomes, including long-term follow-up up to 5 years, of approximately 86 000 heart patients. This study presents the results of both disease- and treatment patient-relevant outcome measures for coronary artery disease and aortic valve disease. The patients included were presented to a Heart Team and underwent invasive or operative treatment. In-hospital and out-of-hospital patient-relevant outcome measures were collected as well as initial conditions. Quality of life was assessed using the Short Form (SF)-36 or SF-12 health survey.
RESULTS: In the Netherlands, patient-relevant and risk-adjusted outcomes of cardiovascular care in participating heart centres are published annually. Data were sufficiently reliable to enable comparisons and to subtract best practices. The statistically lower risk-adjusted mortality rate after coronary artery bypass grafting resulted in a voluntary roll-out of a perioperative safety check. The in-depth analysis of outcomes after percutaneous coronary intervention resulted in process improvements in several heart centres, such as pre-hydration for patients with renal insufficiency and the need of target vessel revascularizations within a year.
CONCLUSION: Annual data collection on follow-up of patient-relevant outcomes of cardiovascular care, initiated and organized by physicians, appears feasible. Transparent publication of outcomes drives the improvement of quality within heart centres. The system of using a limited set of patient-relevant outcome measures enables reliable comparisons and exposes the quality of decision-making and the operational process. Transparent communication on outcomes is feasible, safe and cost-effective, and stimulates professional decision-making and disease management.
© The Author 2016. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Cardiovascular; Outcomes; Patient-relevant; Quality improvement; Transparency; Value-based healthcare

Mesh:

Year:  2016        PMID: 26984991     DOI: 10.1093/ejcts/ezw034

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  12 in total

1.  Trends in Coronary Revascularization and Ischemic Heart Disease-Related Mortality in Israel.

Authors:  Orit Blumenfeld; Wasef Na'amnih; Ayelet Shapira-Daniels; Chaim Lotan; Tamy Shohat; Oz M Shapira
Journal:  J Am Heart Assoc       Date:  2017-02-17       Impact factor: 5.501

2.  Improving clinical outcomes and patient satisfaction among patients with coronary artery disease: an example of enhancing regional integration between a cardiac centre and a referring hospital.

Authors:  Dennis van Veghel; Mohamed Soliman-Hamad; Daniela N Schulz; Bernard Cost; Timothy A Simmers; Lukas R C Dekker
Journal:  BMC Health Serv Res       Date:  2020-06-03       Impact factor: 2.655

3.  Patient-relevant outcomes: what are we talking about? A scoping review to improve conceptual clarity.

Authors:  Christine Kersting; Malte Kneer; Anne Barzel
Journal:  BMC Health Serv Res       Date:  2020-06-29       Impact factor: 2.655

4.  Quality of life after coronary bypass: a multicentre study of routinely collected health data in the Netherlands†.

Authors:  Fredrike Blokzijl; Saskia Houterman; Bart H M van Straten; Edgar Daeter; George J Brandon Bravo Bruinsma; Willem Dieperink; Michiel F Reneman; Frederik Keus; Iwan C C van der Horst; Massimo A Mariani
Journal:  Eur J Cardiothorac Surg       Date:  2019-09-01       Impact factor: 4.191

5.  Better survival after transcatheter aortic valve replacement by process improvements.

Authors:  G J van Steenbergen; D van Veghel; D N Schulz; M Soliman-Hamad; P A Tonino; S Houterman; L Dekker
Journal:  Neth Heart J       Date:  2020-12-07       Impact factor: 2.380

Review 6.  The implementation of value-based healthcare: a scoping review.

Authors:  Dorine J van Staalduinen; Petra van den Bekerom; Sandra Groeneveld; Martha Kidanemariam; Anne M Stiggelbout; M Elske van den Akker-van Marle
Journal:  BMC Health Serv Res       Date:  2022-03-01       Impact factor: 2.655

7.  Validation of the society of thoracic surgeons predicted risk of mortality score for long-term survival after cardiac surgery in Israel.

Authors:  Eyal I Ben-David; Orit Blumenfeld; Ayelet Shapira-Daniels; Oz M Shapira
Journal:  J Cardiothorac Surg       Date:  2022-04-05       Impact factor: 1.637

Review 8.  Using real-world data to monitor and improve quality of care in coronary artery disease: results from the Netherlands Heart Registration.

Authors:  Marijke J C Timmermans; Saskia Houterman; Edgar D Daeter; Peter W Danse; Wilson W Li; Erik Lipsic; Maaike M Roefs; Dennis van Veghel
Journal:  Neth Heart J       Date:  2022-04-07       Impact factor: 2.380

9.  Quality measurement for cardiovascular diseases and cancer in hospital value-based healthcare: a systematic review of the literature.

Authors:  Rawia Abdalla; Milena Pavlova; Mohammed Hussein; Wim Groot
Journal:  BMC Health Serv Res       Date:  2022-08-01       Impact factor: 2.908

10.  Selecting interventions to improve patient-relevant outcomes in health care for aortic valve disease - the Intervention Selection Toolbox.

Authors:  Nina Zipfel; A Stef Groenewoud; Benno J W M Rensing; Edgar J Daeter; Lea M Dijksman; Jan-Henk E Dambrink; Philip J van der Wees; Gert P Westert; Paul B van der Nat
Journal:  BMC Health Serv Res       Date:  2020-03-19       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.